Wells Fargo Maintains Overweight on MorphoSys, Raises Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Derek Archila has maintained an Overweight rating on MorphoSys (NASDAQ:MOR) and increased the price target from $10 to $17.
December 15, 2023 | 5:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst Derek Archila reaffirmed an Overweight rating on MorphoSys and raised the price target to $17 from $10.
The increase in price target by a reputable analyst typically signals a positive outlook on the company's future performance, which can lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100